24/4/19 -
Malaria vaccination begins
The first ever national malaria vaccine campaign was launched yesterday in the African country
of Malawi. More
24/4/19 - Hope for repairing foetal membranes
New discoveries could enable successful treatment of ruptured foetal membranes, British researchers
have reported. More
24/4/19 - Gene link to cannabis addiction
Genetics plays a role in individual risk of becoming addicted to cannabis, British researchers
reported today. More
23/4/19 -
New genetic variants linked to obesity
Scientists working on weight-loss therapies have been investigating receptors on cell surfaces
called G protein-coupled receptors. More
23/4/19 - NHS to support neurosurgery for hearing impaired infants
Two centres in England are to be funded to provide auditory brainstem implants, it has been
announced. More
18/4/19
- Cure claim for SCID gene therapy
Gene therapy developed for babes with severe combined immunodeficiency
may have successfully "cured" all of those who received treatment,
doctors claimed last night. More
18/4/19 - Abandoned diabetes drug shows lymphoma promise
A drug abandoned as a treatment for diabetes may protect against the
development of T-cell lymphoma, Scottish researchers have reported. More
17/4/19 - Breast cancer relapse test backed
A new blood test could detect breast cancer relapse two years earlier
than imaging tests, British researchers have reported. More
17/4/19 - Astronaut experiment for spine health
A space medicine research programme could help develop treatments for
spinal postural deconditioning, according to a UK-based team. More
16/4/19 - Global measles outbreak warning
Rates of measles have quadrupled this year globally, including in Europe,
the World Health Organisation has warned. More
16/4/19 - Diabetes drug protects against kidney disease
A drug developed to help people with diabetes has been found to reduce
heart failure, major cardiovascular events and protect against kidney
failure. More
16/4/19 - Statins failing half of patients – but do they take them?
Half of patients prescribed statins do not achieve the necessary “healthy”
cholesterol levels after two years of treatment, according to a new observational
study. More
Printer friendly page